234 related articles for article (PubMed ID: 33009490)
1. RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors.
Wang WL; Gokgoz N; Samman B; Andrulis IL; Wunder JS; Demicco EG
Mod Pathol; 2021 May; 34(5):951-960. PubMed ID: 33009490
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
3. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?
Mosquera JM; Fletcher CD
Am J Surg Pathol; 2009 Sep; 33(9):1314-21. PubMed ID: 19718788
[TBL] [Abstract][Full Text] [Related]
4. TERT promoter mutations and prognosis in solitary fibrous tumor.
Bahrami A; Lee S; Schaefer IM; Boland JM; Patton KT; Pounds S; Fletcher CD
Mod Pathol; 2016 Dec; 29(12):1511-1522. PubMed ID: 27562490
[TBL] [Abstract][Full Text] [Related]
5. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
6. Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features.
Ronchi A; Cozzolino I; Zito Marino F; Accardo M; Montella M; Panarese I; Roccuzzo G; Toni G; Franco R; De Chiara A
Ann Diagn Pathol; 2018 Jun; 34():142-150. PubMed ID: 29660566
[TBL] [Abstract][Full Text] [Related]
7. PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.
Gelmi MC; Gezgin G; van der Velden PA; Luyten GPM; Luk SJ; Heemskerk MHM; Jager MJ
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):36. PubMed ID: 38149971
[TBL] [Abstract][Full Text] [Related]
8. NAB2-STAT6 gene fusion and STAT6 immunoexpression in extrathoracic solitary fibrous tumors: the association between fusion variants and locations.
Chuang IC; Liao KC; Huang HY; Kao YC; Li CF; Huang SC; Tsai JW; Chen KC; Lan J; Lin PC
Pathol Int; 2016 May; 66(5):288-96. PubMed ID: 27039712
[TBL] [Abstract][Full Text] [Related]
9. Extensive survey of STAT6 expression in a large series of mesenchymal tumors.
Demicco EG; Harms PW; Patel RM; Smith SC; Ingram D; Torres K; Carskadon SL; Camelo-Piragua S; McHugh JB; Siddiqui J; Palanisamy N; Lucas DR; Lazar AJ; Wang WL
Am J Clin Pathol; 2015 May; 143(5):672-82. PubMed ID: 25873501
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of STAT6 in solitary fibrous tumor].
Ding ZY; Wang YF; Wang X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):235-239. PubMed ID: 28376588
[No Abstract] [Full Text] [Related]
12. Solitary Fibrous Tumors in Pediatric Patients: A Rare and Potentially Overdiagnosed Neoplasm, Confirmed by STAT6 Immunohistochemistry.
Tan SY; Szymanski LJ; Galliani C; Parham D; Zambrano E
Pediatr Dev Pathol; 2018; 21(4):389-400. PubMed ID: 29228868
[TBL] [Abstract][Full Text] [Related]
13. PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer.
Cassalia F; Danese A; Tudurachi I; Federico S; Zambello A; Guidotti A; Franceschin L; Bolzon A; Naldi L; Belloni Fortina A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338862
[TBL] [Abstract][Full Text] [Related]
14. PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.
Kaczorowski M; Chłopek M; Kruczak A; Ryś J; Lasota J; Miettinen M
Am J Surg Pathol; 2022 Nov; 46(11):1467-1476. PubMed ID: 35973038
[TBL] [Abstract][Full Text] [Related]
15. A Case of Solitary Fibrous Tumor of the Cheek.
Otsuru M; Aoki T; Ota Y; Takahashi M; Uchibori M; Aoyama K; Kondo Y
Tokai J Exp Clin Med; 2016 Sep; 41(3):139-42. PubMed ID: 27628606
[TBL] [Abstract][Full Text] [Related]
16. Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential.
Naik A; Thomas R; Al-Khadairi G; Bacha R; Hendrickx W; Decock J
J Cell Mol Med; 2021 Nov; 25(22):10376-10388. PubMed ID: 34612587
[TBL] [Abstract][Full Text] [Related]
17. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
[TBL] [Abstract][Full Text] [Related]
18. Solitary fibrous tumour of the lower leg: an uncommon site with atypical histopathological features.
Sherwani RK; Kumar A
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791854
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Thongprasert S; Yang PC; Lee JS; Soo R; Gruselle O; Myo A; Louahed J; Lehmann FF; Brichard VG; Coche T
Lung Cancer; 2016 Nov; 101():137-144. PubMed ID: 27794402
[TBL] [Abstract][Full Text] [Related]
20. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]